Results

Total Results: 727 records

Showing results for "free".

721. Core Needle and Open Surgical Biopsy for Diagnosis of Breast Lesions — An Update to the 2009 Report | Effective Health Care (EHC) Program
     effectivehealthcare.ahrq.gov/products/breast-biopsy-update/research-protocol
     September 20, 2013 - Recurrence rate (for women with cancer, including local, regional, and distant recurrence) Cancer-free

722. Treatment for Bipolar Disorder | Effective Health Care (EHC) Program
     effectivehealthcare.ahrq.gov/products/bipolar-disorder-treatment/research-protocol
     June 23, 2014 - Are reports of the study free of suggestion of selective outcome reporting?

723. Disposition of Comments for CER 176 Management of Gout (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/related_files/gout-management-disposition-160721.pdf
     March 15, 2016 - Using serum urate levels to determine the period free of gouty symptoms after withdrawal of long-term … 2 years without symptomatic gout), compared with patients in the lowest sUA range who had symptom-free … Again, please feel free to contact me if additional information is needed.

724. Dispostion of Comments Report for Screening for Hepatitis C Virus Infection in Adults (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/related_files/hepatitis-c-screening_disposition-comments.pdf
     November 27, 2012 - Treatment is rapidly evolving and we may well have an interferon-free, 3-month, all-oral regimen with … given hope for better outcomes for those with timely diagnosis, and (c) the prospect of interferon-free … next 5 years it is anticipated that these percentages will increase further with an oral (interferon-free

725. Diabetes Mellitus (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/diabetes-horizon-scan-high-impact-1406.pdf
     September 26, 2014 - At week 52, IDeg Free-Flex subjects had similar glycosylated hemoglobin but greater fasting plasma … Forced-Flex vs IDeg (37%; P = .003) and IGlar (40%; P = .001) at week 26 and 25% lower with IDeg Free-Flex … Long- term, injection-free treatment with ITCA 650, a continuous subcutaneous delivery of exenatide

726. Disposition of Comments for PCA3 Testing for the Diagnosis and Management of Prostate Cancer (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/related_files/prostate-cancer-test_disposition-comments.pdf
     April 01, 2013 - of 174, line 35: consider defining tPSA as total PSA; later on in the Exec Summary you use fPSA for free … reference ranges (see above), BPH and prostate size, previous PSA values (PSA velocity) if available, free

727. Comparative Effectiveness of Fecal DNA Testing in Screening for Colorectal Cancer in Average Risk Adults. (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/related_files/colorectal-cancer-screening_disposition-comments.pdf
     February 01, 2012 - This is why specificity in the studies, historically, considers a colon free of neoplasia or with only … This is why specificity in the studies, historically, considers a colon free of neoplasia or with only